These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22828265)

  • 1. Allergic contact dermatitis syndrome from bufexamac for nursing infant.
    Nakada T; Matsuzawa Y
    Dermatitis; 2012; 23(4):185-6. PubMed ID: 22828265
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.
    Arikawa J; Okabe S; Kaneko T
    J Dermatol; 2004 Feb; 31(2):136-8. PubMed ID: 15160871
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
    Wong GN; Shen S; Nixon R
    Contact Dermatitis; 2019 Jun; 80(6):395-397. PubMed ID: 30624772
    [No Abstract]   [Full Text] [Related]  

  • 5. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
    Proske S; Uter W; Schnuch A; Hartschuh W
    Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis from bufexamac cream.
    Corazza M; Roveggio C; Virgili A
    Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs.
    Gniazdowska B; Ruëff F; Przybilla B
    Contact Dermatitis; 1999 Feb; 40(2):63-5. PubMed ID: 10048648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
    Barbaud A; Tréchot P; Aublet-Cuvelier A; Reichert-Penetrat S; Schmutz JL
    Contact Dermatitis; 1998 Nov; 39(5):272-3. PubMed ID: 9840280
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
    Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
    Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe contact dermatitis caused by Parfenac cream].
    Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
    Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact sensitivity to budesonide in a child.
    Auricchio L; Nino M; Suppa F
    Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe contact dermatitis caused by bufexamac with large flap desquamation].
    Landrieux C; Estève E; Serpier H; Kalis B
    Ann Dermatol Venereol; 1996; 123(3):198-9. PubMed ID: 8761786
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
    Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
    Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis due to indomethacin and diclofenac.
    Gómez A; Florido JF; Quiralte J; Martín AE; Sáenz de San Pedro B
    Contact Dermatitis; 2000 Jul; 43(1):59. PubMed ID: 10902602
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact dermatitis caused by bufexamac sparing the eruption of herpes zoster.
    Fukuda H; Sato Y; Usami N; Yokouchi Y; Mukai H
    J Dermatol; 2012 Apr; 39(4):405-7. PubMed ID: 21950459
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical NSAID allergic contact dermatitis. Italian experience.
    Pigatto PD; Mozzanica N; Bigardi AS; Legori A; Valsecchi R; Cusano F; Tosti A; Guarrera M; Balato N; Sertoli A
    Contact Dermatitis; 1993 Jul; 29(1):39-41. PubMed ID: 8365153
    [No Abstract]   [Full Text] [Related]  

  • 19. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac.
    Kurumaji Y
    Dermatology; 1998; 197(2):183-6. PubMed ID: 9732173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact sensitivity to 5 different ingredients of a topical medicament (Imacort cream).
    Brand CU; Ballmer-Weber BK
    Contact Dermatitis; 1995 Aug; 33(2):137. PubMed ID: 8549141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.